The cheRNA ZEB1-AS1 was shown to promote the occurrence of prostate cancer via recruiting histone methyltransferase MLL1 to the promoter region of ZEB1, inducing H3K4me3 modification, and thus activating ZEB1 transcription (Su et al., 2017). Here, ZEB1 is linked to prostate carcinoma.